Computer-assisted Cognitive Rehabilitation (CACR), Placebo CACR and Psycho-stimulants in the Treatment of ADHD
NCT ID: NCT01675804
Last Updated: 2015-04-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
34 participants
INTERVENTIONAL
2011-11-30
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive-Motor Rehabilitation, Stimulant Drugs, and Active Control in the Treatment of ADHD
NCT02780102
Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
NCT00050622
Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder
NCT02951754
KP415 Classroom Study in Children (6-12 Years of Age) With ADHD
NCT03292952
Impact of Stimulants and In-Scanner Motion on Attentive Task Performance in ADHD (ADHD_NFB)
NCT06779825
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Computerized cognitive rehabilitation
-Computer-assisted cognitive rehabilitation (CACR): 20 Ninety-minute sessions of CACR.
Computerized cognitive rehabilitation
\- Computerized cognitive rehabilitation: 20 ninety-minute sessions of computerized cognitive rehabilitation.
Placebo CACR [PCACR]
-PCACR group simultaneously received 20 Ninety-minute sessions of Placebo CACR.
Placebo CACR [PCACR]
PCACR: 20 ninety-minute sessions of Placebo computerized cognitive training.
Ritalin
-2 to 3 doses of 10 mg Ritalin tablets per day during two months.
Ritalin
-drug therapy: 2 or 3 doses of 10 mg tablets of Immediate-release Methylphenidate (Ritalin) per day for 2 months.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Computerized cognitive rehabilitation
\- Computerized cognitive rehabilitation: 20 ninety-minute sessions of computerized cognitive rehabilitation.
Ritalin
-drug therapy: 2 or 3 doses of 10 mg tablets of Immediate-release Methylphenidate (Ritalin) per day for 2 months.
Placebo CACR [PCACR]
PCACR: 20 ninety-minute sessions of Placebo computerized cognitive training.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age between 7 and 12
* IQ \> 85
Exclusion Criteria
* seizure
* IQ \< 85
* disability
* sever medical condition
7 Years
12 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Allameh Tabatabai University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Saeed Azami, MSc
Role: PRINCIPAL_INVESTIGATOR
Candidate for PhD in Psychology, Department of Psychology, Semnan University, Semnan, Iran
Alireza Moghadas, PhD
Role: STUDY_DIRECTOR
Department of Clinical Psychology, Allameh Tabatabaei University, Tehran, Iran.
Faramarz Sohrabi, PhD
Role: STUDY_DIRECTOR
Department of Clinical Psychology, Allameh Tabatabaei University, Tehran, Iran.
Morteza Nazifi, PhD
Role: STUDY_DIRECTOR
Department of psychology, University of Bojnord, Bojnord, Iran.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Counseling and guidence Center of the Department of education of region 9 of Tehran
Tehran, Tehran Province, Iran
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
83-6516
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.